MOESM2 of OX40L induces helper T cell differentiation during cell immunity of asthma through PI3K/AKT and P38 MAPK signaling pathway

Additional file 2. Flow cytometric analysis of Th1, Th2, Th17 and Treg in OVA-challenged CD4+ T cells treated with OX40L-Ig fusion protein and PI3K/Akt inhibitor, LY294002 or p38MAPK inhibitor SB203580.